Literature DB >> 12823640

Insomnia, metabolic rate and sleep restoration.

M H Bonnet1, D L Arand.   

Abstract

Studies have shown occasional evidence of increased physiological activity in patients with primary insomnia. We hypothesized that metabolic rate, as measured by overall oxygen use (VO2), might be a more general index of increased physiological activity. An initial experiment found elevated VO2 both at night and during the day in patients with primary insomnia as compared with matched normal sleepers. A second experiment found significant but more modest increases in VO2 in patients with Sleep State Misperception Insomnia [who complain of poor sleep but who had normal sleep by electroencephalographic (EEG) criteria]. In a third experiment, normal young adults were given caffeine 400 mg three times per day (TID) for 1 week as a means of increasing VO2 and possibly producing other symptoms of insomnia. Participants developed many symptoms consistent with those seen in patients with primary insomnia (poor sleep, increased latency on the Multiple Sleep Latency Test, increasing fatigue despite physiological activation, and increased anxiety on the Minnesota Multiphasic Personality Inventory (MMPI)). In a final experiment, physiological arousal was again produced by caffeine to determine if sleep with elevated arousal would be less restorative. All subjects (Ss) slept for 3.5 h after being given 400 mg of caffeine. During 41 h of sleep deprivation that followed, there was no significant condition difference for the Multiple Sleep Latency Test or mood measures. The results provided only weak support for the idea that sleep is less restorative after physiological arousal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823640     DOI: 10.1046/j.1365-2796.2003.01176.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  16 in total

Review 1.  Orexin receptors: pharmacology and therapeutic opportunities.

Authors:  Thomas E Scammell; Christopher J Winrow
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

2.  Afferents to the orexin neurons of the rat brain.

Authors:  Kyoko Yoshida; Sarah McCormack; Rodrigo A España; Amanda Crocker; Thomas E Scammell
Journal:  J Comp Neurol       Date:  2006-02-10       Impact factor: 3.215

Review 3.  Enhancement of slow wave sleep: implications for insomnia.

Authors:  James K Walsh
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

4.  Insomnia as a cardiometabolic risk factor.

Authors:  Michael A Grandner; Michael L Perlis
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

5.  Sleep-wake time perception varies by direct or indirect query.

Authors:  Y Alameddine; J M Ellenbogen; M T Bianchi
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

6.  Energy expenditure is affected by rate of accumulation of sleep deficit in rats.

Authors:  Aimee M Caron; Richard Stephenson
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

7.  Sleep, aging, and lifespan in Drosophila.

Authors:  Daniel Bushey; Kimberly A Hughes; Giulio Tononi; Chiara Cirelli
Journal:  BMC Neurosci       Date:  2010-04-29       Impact factor: 3.288

8.  CHRONIC INSOMNIA AND STRESS SYSTEM.

Authors:  Maria Basta; George P Chrousos; Antonio Vela-Bueno; Alexandros N Vgontzas
Journal:  Sleep Med Clin       Date:  2007-06

9.  Regional Patterns of Elevated Alpha and High-Frequency Electroencephalographic Activity during Nonrapid Eye Movement Sleep in Chronic Insomnia: A Pilot Study.

Authors:  Brady A Riedner; Michael R Goldstein; David T Plante; Meredith E Rumble; Fabio Ferrarelli; Giulio Tononi; Ruth M Benca
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

10.  The options available in cognitive behavioral therapy to prevent chronification of insomnia.

Authors:  Tatjana Crönlein; Jürgen Zulley
Journal:  EPMA J       Date:  2011-07-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.